Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
|Articles|August 20, 2003
Philips beams over IMV ratings
A survey of medical facilities in the U.S. has pegged Philips Medical Systems as the market leader in cardiac cath with a 40% market share and the largest installed base, according to the Dutch company. Philips is the most frequently considered
Advertisement
A survey of medical facilities in the U.S. has pegged Philips Medical Systems as the market leader in cardiac cath with a 40% market share and the largest installed base, according to the Dutch company. Philips is the most frequently considered manufacturer for the next cath lab imaging system purchase: 56% of surveyed sites mentioned the company, and 77% of Philips sites stated they would consider the company again for future purchases. Data were obtained by IMV Limited, an independent healthcare research company. Additionally, Philips' market share in x-ray angiography systems increased from 1998 to 2002 to give Philips the largest market share for angio systems installed in 2002.
Advertisement
Related to this article
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
Catch up on the most-well viewed radiology content in September 2026.
The BiPASS program, which combines 68Ga PSMA PET imaging with prostate MRI prior to the use of prostate biopsy, is slated to be evaluated in an impending phase 3 trial.
For patients with localized prostate cancer, stereotactic body radiotherapy (SBRT) offered comparable freedom from biochemical/clinical failure at eight years and nearly 40 percent lower urinary incontinence in comparison to radical prostatectomy, according to research presented at the ASTRO conference.
Catch up on the most well-viewed video interviews from Diagnostic Imaging in September 2026.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Current Perspectives on Integrating AI into Radiology
2
The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 1
3
FDA Grants Fast Track Designation for Pre-Biopsy Use of PSMA PET and MRI for Prostate Cancer Detection
4
Radiology and Building the Alzheimer’s Care Pathway of the Future
5